PeptidePedia The community reference

Trifluoroacetate counterion (revision 7)

Old revision·04:30, 9 Nov 2024·FreightFenna

This is an old revision of this page, as it stood at 04:30, 9 Nov 2024, saved by FreightFenna with the summary correct the resolution formula — the denominator is the sum of the widths. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Trifluoroacetate counterion
AbbreviationTFA salt
Arises fromTrifluoroacetic acid modifier in RP-HPLC
Typical content5–25% of solid mass, sequence-dependent
AlternativeAcetate, hydrochloride, by salt exchange
Topic infobox · conventions

Trifluoroacetate is the counterion carried by most synthetic peptides purified by reverse-phase chromatography, because trifluoroacetic acid is the standard mobile-phase modifier and the peptide is isolated from that mobile phase by lyophilisation.[1]

The counterion pairs with basic side chains — lysine, arginine, histidine — and with the N-terminal amine, so its mass fraction depends on how many basic residues the sequence carries. For a peptide with several, trifluoroacetate can be a substantial fraction of the solid, commonly cited in the range of 5–25%.[2]

This matters because that mass is not peptide. A vial containing 5 mg of solid at 15% trifluoroacetate and 6% water contains under 4 mg of peptide even at high chromatographic purity — which is why peptide content and purity are separate determinations answering separate questions.[1]

Origin and removal

[edit]

Trifluoroacetic acid is used as an ion-pairing modifier because it sharpens peptide peaks considerably; the resulting separation is better than with most alternatives. It is also used in the cleavage step of Fmoc synthesis, so the peptide encounters it twice.[1]

Removal requires salt exchange, most often by repeated lyophilisation from dilute hydrochloric or acetic acid, or by an ion-exchange step. Exchange is not free: it costs a processing step and some yield, and the resulting acetate or hydrochloride salt has its own mass contribution.

Complete removal is difficult, and residual trifluoroacetate persists at low levels even after exchange. A certificate reporting an acetate salt should therefore also report residual trifluoroacetate if the exchange is to be evidenced rather than asserted.[2]

References

  1. ^ a b c United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
  2. ^ a b Roux S, Zékri E, Rousseau B, et al. "Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches." Journal of Peptide Science 14(3):354–359 (2008). PMID 17994590.